Skip to main content
Funded Studies

Armin Giese

Chief Scientific Officer at MODAG GmbH

Location: Wendelsheim Germany

Dr. Armin Giese was acting head of department at the Center for Neuropathology and Prion Research at the University of Munich and acting head of the German Reference Center for Neurodegenerative Diseases (DGNN). He holds a Bachelor of Science degree from the University College London, Medical Licenses from the University of Kiel, and a Doctor of Medicine from the University of Göttingen. Prof. Dr. Giese is a board-certified neuropathologist and has published more than 140 scientific papers. His work focuses on the role of protein aggregation in neurodegenerative diseases. Prof. Dr. Giese developed new high-throughput methods for the detection of protein oligomers and for the screening of aggregation inhibitors based on single particle spectroscopy. Utilizing this technology, he identified novel aggregation inhibitors with excellent medical-chemical properties and high in vivo efficacy. Based on these findings, he co-founded MODAG in 2013 and serves as its chief scientific officer.


Associated Grants

  • Pharmacokinetics, Food Effects, Safety and Tolerability of Aggregation Inhibitor Anle138b in Parkinson´s Disease

    2022


  • Preclinical Testing of a Novel Tracer for Imaging Alpha-synuclein Aggregates

    2021


  • Development of Selective Markers for Imaging Abnormal Protein Aggregates in Parkinson’s Disease

    2021


  • Anle138b Clinical Phase 1 Studies: Food Effect, Safety and Tolerability as well as Pharmacokinetics in Parkinson´s Disease Patients

    2020


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.